Health Care & Life Sciences » Pharmaceuticals | Gennex Laboratories Ltd.

Gennex Laboratories Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
349,519.60
318,627.70
384,930.00
418,895.00
437,745.70
Cost of Goods Sold (COGS) incl. D&A
307,797.70
280,204.10
172,592.20
334,644.50
379,245.10
Gross Income
41,721.90
38,423.50
212,337.80
84,250.50
58,500.60
SG&A Expense
34,030.10
27,378.90
178,793.70
46,939.10
45,029.30
EBIT
7,691.80
11,074.80
33,368.10
-
13,471.30
Unusual Expense
61.50
224.70
187.00
12.00
422.20
Non Operating Income/Expense
1,914.80
1,515.30
92.20
457.60
7,101.10
Interest Expense
3,202.70
4,763.50
5,038.00
7,054.00
7,311.40
Pretax Income
6,980.20
8,471.20
30,333.90
31,008.00
14,533.30
Income Tax
4,918.00
1,930.50
6,964.80
3,964.80
6,175.60
Consolidated Net Income
2,062.20
6,540.70
23,369.10
27,043.30
8,357.70
Net Income
2,062.20
6,540.70
23,369.10
27,043.30
8,357.70
Net Income After Extraordinaries
2,062.20
6,540.70
23,369.10
27,043.30
8,357.70
Net Income Available to Common
2,062.20
6,540.70
23,369.10
27,043.30
8,357.70
EPS (Basic)
0.02
0.05
0.19
0.21
0.07
Basic Shares Outstanding
126,503.00
126,503.00
126,503.00
126,503.00
126,503.00
EPS (Diluted)
0.02
0.05
0.18
0.21
0.07
Diluted Shares Outstanding
126,503.00
126,503.00
126,503.00
126,503.00
126,503.00
EBITDA
15,890.60
19,935.40
41,728.70
45,700.50
22,689.80
Other Operating Expense
-
30.10
176.10
5.20
-
Non-Operating Interest Income
514.70
419.90
469.80
286.20
850.10

About Gennex Laboratories

View Profile
Address
Akash Ganga
Hyderabad TS 500073
India
Employees -
Website http://www.gennexlab.com
Updated 09/14/2018
Gennex Laboratories Ltd. engages in the manufacture of bulk drugs and intermediates products. It operates through the following geographical segments: Germany, Egypt, Iran, Peru, Bangladesh, Spain, Guatemala City, El Salvador, Vietnam, Export Others, and India. Its products include Guaifenesin, Methocarbamol, Phenazopyridine Hydrochloride, Fluconazole, Metformin Hcl, Ambroxol Hcl, and Melitracen Hydrochloride.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.